All Stories

  1. Ibogaine: Revisiting an Ancient Alkaloid for Modern Opioid Dependence

    Article • Substance Use & Misuse, December 2025, Taylor & Francis

    Dr Saeed K. Alzghari

  2. Subcutaneous immune checkpoint inhibitors: A new era in oncology care

    Article • Journal of Oncology Pharmacy Practice, October 2025, SAGE Publications

    Dr Saeed K. Alzghari

  3. MT-45: A Synthetic Opioid With an Unusual Adverse Effect Profile

    Article • Cureus, May 2025, Springer Science + Business Media

    Dr Saeed K. Alzghari

  4. Dobutamine-Induced Myoclonus in a Patient With Acute Decompensated Heart Failure and Acute Kidney Injury: A Case Report and Literature Review

    Article • Cureus, January 2025, Springer Science + Business Media

    Dr Saeed K. Alzghari

  5. Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review

    Article • Journal of Clinical Virology, June 2020, Elsevier

    Dr Saeed K. Alzghari

  6. Treating Non-fentanyl-derived Synthetic Opioid Overdose with a Traditional Opioid Reversal Agent

    Article • Cureus, March 2020, Springer Science + Business Media

    Dr Saeed K. Alzghari

  7. Optimizing Patient Outcomes with PD‐1/PD‐L1 Immune Checkpoint Inhibitors for the First‐Line Treatment of Advanced Non–Small Cell Lung Cancer

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2020, Wiley

    Dr Saeed K. Alzghari

  8. Diuretics

    Article • January 2020, Elsevier

    Dr Saeed K. Alzghari

  9. Gamer's Thrombosis: A Review of Published Reports

    Article • Ochsner Journal, January 2020, Ochsner Journal

    Dr Saeed K. Alzghari

  10. The Road to a Hypoglycemic Care Model

    Article • Cureus, October 2019, Springer Science + Business Media

    Dr Saeed K. Alzghari

  11. Systematic review of the clinical consequences of butyrfentanyl and corresponding analogues

    Article • Interdisciplinary Toxicology, October 2019, De Gruyter

    Dr Saeed K. Alzghari

  12. Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes: It takes two to tango

    Article • American Journal of Hematology, April 2019, Wiley

    Dr Saeed K. Alzghari

  13. Peer review and publication delay

    Article • Pharmacy Practice, March 2019, Centro de Investigaciones y Publicaciones Farmaceuticas (CIPF)

    Dr Saeed K. Alzghari, Dr Souheil Hallit

  14. Positive inotropic drugs and drugs used in dysrhythmias

    Article • January 2019, Elsevier

    Dr Saeed K. Alzghari

  15. Chapter 40: Nausea and Vomiting

    Article • November 2018, American Society of Health System Pharmacists

    Dr Saeed K. Alzghari

  16. The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety

    Article • Cureus, August 2018, Cureus, Inc.

    Dr Saeed K. Alzghari

  17. Evaluation of Factors which Influence Mortality in Gram-positive Bacteremia in Hemodialysis Patients

    Article • Cureus, July 2018, Cureus, Inc.

    Dr Saeed K. Alzghari

  18. A Review of the Opioid Analgesic Benzhydrocodone-Acetaminophen

    Article • Cureus, June 2018, Cureus, Inc.

    Dr Saeed K. Alzghari

  19. AH-7921: A review of previously published reports

    Article • Baylor University Medical Center Proceedings, June 2018, Taylor & Francis

    Dr Saeed K. Alzghari

  20. Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease

    Article • Cureus, May 2018, Cureus, Inc.

    Dr Saeed K. Alzghari

  21. An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity

    Article • Cureus, April 2018, Cureus, Inc.

    Dr Saeed K. Alzghari

  22. Pain Perception and the Opioid Receptor Delta 1

    Article • Cureus, February 2018, Cureus, Inc.

    Dr Saeed K. Alzghari

  23. Addressing Hazards from Unscheduled Novel Psychoactive Substances as Research Chemicals: The Case of U-50488

    Article • Cureus, December 2017, Cureus, Inc.

    Dr Saeed K. Alzghari

  24. Correction to: Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis

    Article • European Journal of Drug Metabolism and Pharmacokinetics, November 2017, Springer Science + Business Media

    Dr Saeed K. Alzghari

  25. U-47700: An Emerging Threat

    Article • Cureus, October 2017, Cureus, Inc.

    Dr Saeed K. Alzghari

  26. Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis

    Article • European Journal of Drug Metabolism and Pharmacokinetics, October 2017, Springer Science + Business Media

    Dr Saeed K. Alzghari

  27. Methylenetetrahydrofolate Reductase A1298C Polymorphism and Major Depressive Disorder

    Article • Cureus, October 2017, Cureus, Inc.

    Dr Saeed K. Alzghari

  28. On the Horizon: The Synthetic Opioid U-49900

    Article • Cureus, September 2017, Cureus, Inc.

    Dr Saeed K. Alzghari

  29. To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates

    Article • Cureus, September 2017, Cureus, Inc.

    Dr Saeed K. Alzghari

  30. U-47700: A Clinical Review of the Literature

    Article • Journal of Emergency Medicine, September 2017, Elsevier

    Dr Saeed K. Alzghari

  31. The Current Landscape of Marijuana and Pharmacogenetics

    Article • Cureus, July 2017, Cureus, Inc.

    Dr Saeed K. Alzghari

  32. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study

    Article • Journal of Oncology Pharmacy Practice, July 2017, SAGE Publications

    Dr Saeed K. Alzghari

  33. Interprofessional education and distance education: A review and appraisal of the current literature

    Article • Currents in Pharmacy Teaching and Learning, July 2017, Elsevier

    Dr Saeed K. Alzghari

  34. Proposal for a Pharmacogenetic Decision Algorithm

    Article • Cureus, May 2017, Cureus, Inc.

    Dr Saeed K. Alzghari

  35. Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context

    Article • Therapeutics and Clinical Risk Management, February 2017, Dove Medical Press

    Alexander Le, Dr. Gary W. Jean, Dr Saeed K. Alzghari

  36. Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine

    Article • Journal of Oncology Pharmacy Practice, August 2016, SAGE Publications

    Dr Saeed K. Alzghari

  37. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin

    Article • Journal of Controlled Release, June 2016, Elsevier

    Dr Saeed K. Alzghari

  38. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2015, Wiley

    Dr Saeed K. Alzghari

  39. The Role of Pegylated Liposomal Doxorubicin in Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials

    Article • The Oncologist, July 2013, Alphamed Press

    Dr Saeed K. Alzghari

  40. Synthesis of the Pentacyclic Skeleton of the Indole Alkaloid Arboflorine

    Article • Organic Letters, October 2012, American Chemical Society (ACS)

    Dr Saeed K. Alzghari

  41. ChemInform Abstract: Revisiting the Hirao Cross-Coupling: Improved Synthesis of Aryl and Heteroaryl Phosphonates.

    Article • ChemInform, February 2009, Wiley

    Dr Saeed K. Alzghari

  42. Revisiting the Hirao cross-coupling: improved synthesis of aryl and heteroaryl phosphonates

    Article • Journal of Organometallic Chemistry, September 2008, Elsevier

    Dr Saeed K. Alzghari